122,100 Shares in Paysign, Inc. $PAYS Acquired by Strs Ohio

Strs Ohio purchased a new position in shares of Paysign, Inc. (NASDAQ:PAYS) during the first quarter, according to its most recent 13F filing with the SEC. The institutional investor purchased 122,100 shares of the company’s stock, valued at approximately $259,000. Strs Ohio owned about 0.23% of Paysign at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of the company. Jane Street Group LLC acquired a new position in Paysign during the 1st quarter worth $51,000. Goldman Sachs Group Inc. raised its stake in Paysign by 7.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 258,334 shares of the company’s stock worth $548,000 after buying an additional 17,466 shares during the period. Nuveen LLC acquired a new stake in shares of Paysign in the 1st quarter valued at about $95,000. GSA Capital Partners LLP raised its stake in shares of Paysign by 38.3% in the 1st quarter. GSA Capital Partners LLP now owns 271,781 shares of the company’s stock valued at $576,000 after purchasing an additional 75,311 shares during the period. Finally, Royce & Associates LP raised its stake in shares of Paysign by 36.5% in the 1st quarter. Royce & Associates LP now owns 19,319 shares of the company’s stock valued at $41,000 after purchasing an additional 5,166 shares during the period. Institutional investors and hedge funds own 25.89% of the company’s stock.

Analysts Set New Price Targets

A number of research firms recently issued reports on PAYS. DA Davidson set a $9.00 target price on Paysign in a research report on Thursday, August 7th. Lake Street Capital boosted their price objective on Paysign from $9.00 to $10.00 and gave the stock a “buy” rating in a report on Wednesday, August 6th. Four research analysts have rated the stock with a Buy rating, According to data from MarketBeat.com, Paysign has a consensus rating of “Buy” and a consensus target price of $8.56.

Paysign Stock Performance

Shares of NASDAQ:PAYS opened at $5.64 on Thursday. The company has a fifty day moving average of $6.08 and a 200-day moving average of $4.64. The company has a market capitalization of $307.11 million, a PE ratio of 47.00 and a beta of 0.94. Paysign, Inc. has a 52-week low of $1.80 and a 52-week high of $8.88.

Paysign (NASDAQ:PAYS) last announced its quarterly earnings results on Tuesday, August 5th. The company reported $0.02 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.04 by ($0.02). The company had revenue of $19.08 million for the quarter, compared to analyst estimates of $18.69 million. Paysign had a return on equity of 19.32% and a net margin of 9.90%. Paysign has set its Q3 2025 guidance at EPS. FY 2025 guidance at 0.100-0.120 EPS. On average, equities analysts forecast that Paysign, Inc. will post 0.21 EPS for the current fiscal year.

Insiders Place Their Bets

In related news, insider Robert Strobo sold 26,521 shares of the stock in a transaction on Monday, August 4th. The stock was sold at an average price of $7.09, for a total value of $188,033.89. Following the completion of the sale, the insider directly owned 247,290 shares in the company, valued at $1,753,286.10. This represents a 9.69% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, insider Matthew Louis Lanford sold 26,367 shares of the company’s stock in a transaction on Monday, August 4th. The shares were sold at an average price of $7.09, for a total transaction of $186,942.03. Following the sale, the insider directly owned 147,364 shares in the company, valued at $1,044,810.76. This trade represents a 15.18% decrease in their position. The disclosure for this sale can be found here. Insiders sold a total of 159,602 shares of company stock valued at $1,131,578 over the last ninety days. 22.40% of the stock is currently owned by corporate insiders.

Paysign Profile

Paysign, Inc provides prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing services for businesses, consumers, and government institutions. Its product offerings include solutions for corporate rewards, prepaid gift cards, general purpose reloadable debit cards, employee incentives, consumer rebates, donor compensation, clinical trials, healthcare reimbursement payments and pharmaceutical payment assistance, and demand deposit accounts accessible with a debit card.